VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

This study has been terminated.

( Trial re-design; no safety issues identified )

Study NCT01390545 Information provided by Takeda Global Research & Development Center, Inc.

First Received on July 5, 2011. Last Updated on October 24, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Rheumatoid Arthritis

Additional conditions recognized in this trial

Arthritis
Arthritis, Rheumatoid

More general conditions related to this trial

Interventions listed in this trial

Veltuzumab

Additional drug interventions recognized in this trial

Rituximab

More general drug interventions related to this trial

Sponsors listed in this trial